RE: ImmuPharma drug clears a significant hurdle13 Apr 2022 10:55
This is massive news as can proceed with the phase 3 clinical trial for Lupus. The global market is worth 10s of billions. The compound is well tolerated so now can progress. Clear a few tradwrs out from lows and then move on. The U will love this when it opens as will have satisfied the FCA. A £22M MCap is too cheap